A new CSP position was established today on Novartis (NVS). All prices include IB commissions.
| Criteria | Value |
|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $71.00 |
| Target Buy Price | $56.80 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $52.50 |
| Actual Margin of Safety | 26.06% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 1/25/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 52.50 | | ($5,250.00) | |
| 1/25/2012 | NVS | Initial Put Option | STO 1 Mar12 52.50 Put @ 1.18 | | | $117.97 |
Position Summary
| Cost Basis | ($5,250.00) |
| Income Generated | $117.97 |
| Percent Income Generated | 2.25% |
| Annualized Income Generated | 16.08% |
| Net Profit If Assigned | $117.97 |
| Percent Return If Assigned | 2.25% |
| Annualized Return If Assigned | 16.08% |
| Days Held to Expiration | 51 days |
